Stay informed with the latest litigation news. Explore now

IP Verse

Subcutaneous Anti-Her2 Antibody Formulation - EP2687202B1

EP2687202

F HOFFMANN LA ROCHE
Application Number
EP13166031A
Filing Date
Jul 28, 2010
Status
Granted And Under Opposition
Apr 7, 2023
Grant Date
May 10, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2464725B2
EP3559248B2
EP2296728B2

Bibliography

The patent EP2687202B1 was granted to F Hoffmann LA Roche on May 10, 2023 following the initial filing on Jul 28, 2010 under the application number EP13166031A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREFeb 12, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents